SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-302023
Filing Date
2021-10-19
Accepted
2021-10-19 16:31:10
Documents
12
Period of Report
2021-10-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d245949d8k.htm   iXBRL 8-K 23889
  Complete submission text file 0001193125-21-302023.txt   142219

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20211018.xsd EX-101.SCH 2905
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20211018_lab.xml EX-101.LAB 17375
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20211018_pre.xml EX-101.PRE 10962
5 EXTRACTED XBRL INSTANCE DOCUMENT d245949d8k_htm.xml XML 3231
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 211331462
SIC: 3841 Surgical & Medical Instruments & Apparatus